New antibodies target 'dark side' of influenza virus protein

Published on March 1, 2024

Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The antibodies target a region of the NA protein that is common among many influenza viruses, including H3N2 subtype viruses, and could be a new target for countermeasures.

Continue reading on website
Other news

Latest booster reduces adults' risk of moderate or severe COVID by more than half

March 1, 2024
The most recent COVID-19 booster shot reduces adults' risk of moderate or severe COVID by more than half, according to a new nationwide data study from September 2023 through January 2024, a period of JN.1 variant dominance. The new study is one of the first to evaluate protection provided by the updated shot against COVID-19-associated emergency department and urgent care visits (markers for mode

Zika vaccine safe, effective when administered during pregnancy

March 4, 2024
A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research.